Adam C Powell1, Stephen E Price2, Khoa Nguyen3, Gary L Smith4, James W Long5, Uday U Deshmukh6. 1. Director, Outcomes Research, HealthHelp, Houston, TX. 2. Consultant, Clinical Vendor Oversight and Trend Management, Humana, Louisville, KY. 3. Analyst, Medical Economics & Informatics, HealthHelp. 4. Vice President, Medical Economics & Informatics, HealthHelp. 5. Director, Clinical Vendor Oversight and Trend Management, Humana. 6. Chief Medical Officer, HealthHelp.
Abstract
BACKGROUND: In many situations, evidence-based guidelines cannot provide definitive guidance on the appropriateness of diagnostic catheterization. One specialty benefit management company has taken a 2-step approach to address this ambiguity by evaluating the appropriateness of diagnostic catheterization orders using a rule-based decision support system, and then having reviewers provide input through the consult system of a nondenial prior authorization program that involves peer discussion. OBJECTIVE: To describe the outcomes of a 2-step approach to evaluating the appropriateness of elective diagnostic catheterization orders. METHOD: This program evaluation used data from elective diagnostic catheterization orders from 2015 that pertained to 1 health insurer's Medicare Advantage plans. The classifications of orders by the rule-based system and the approval rates after review by the consult system are presented for these plans. Chi-square tests were conducted to examine whether classifications of the orders by the rule-based and consult systems were independent of plan type, specialty of the ordering physician, or state of residence of the patient. RESULTS: A total of 3808 orders for elective diagnostic catheterization in 2015 met the inclusion criteria. Inadequate initial justification was provided for 699 (18.4%) of the orders; after inquiry through the consult system, 509 (72.8%) of the remaining orders were approved. Among the 344 (9%) orders that were deemed potentially nonindicated according to the rule-based system, the consult system approved 298 (86.6%). Of the 2765 (72.6%) orders that were deemed potentially appropriate by the rule-based system, the consult system approved 2740 (99.1%). Chi-square tests did not show a significant association between plan type or physician specialty and the classification produced by the rule-based system or the consult system. The patients' state of residence was significantly associated with the classification of orders for the rule-based system (P <.001), but not for the consult system. CONCLUSION: Rule-based decision support can be combined with consult-based peer discussion to determine whether care is appropriate when guidelines are ambiguous. Poorly justified orders are often supportable after gathering information on the patient's presentation.
BACKGROUND: In many situations, evidence-based guidelines cannot provide definitive guidance on the appropriateness of diagnostic catheterization. One specialty benefit management company has taken a 2-step approach to address this ambiguity by evaluating the appropriateness of diagnostic catheterization orders using a rule-based decision support system, and then having reviewers provide input through the consult system of a nondenial prior authorization program that involves peer discussion. OBJECTIVE: To describe the outcomes of a 2-step approach to evaluating the appropriateness of elective diagnostic catheterization orders. METHOD: This program evaluation used data from elective diagnostic catheterization orders from 2015 that pertained to 1 health insurer's Medicare Advantage plans. The classifications of orders by the rule-based system and the approval rates after review by the consult system are presented for these plans. Chi-square tests were conducted to examine whether classifications of the orders by the rule-based and consult systems were independent of plan type, specialty of the ordering physician, or state of residence of the patient. RESULTS: A total of 3808 orders for elective diagnostic catheterization in 2015 met the inclusion criteria. Inadequate initial justification was provided for 699 (18.4%) of the orders; after inquiry through the consult system, 509 (72.8%) of the remaining orders were approved. Among the 344 (9%) orders that were deemed potentially nonindicated according to the rule-based system, the consult system approved 298 (86.6%). Of the 2765 (72.6%) orders that were deemed potentially appropriate by the rule-based system, the consult system approved 2740 (99.1%). Chi-square tests did not show a significant association between plan type or physician specialty and the classification produced by the rule-based system or the consult system. The patients' state of residence was significantly associated with the classification of orders for the rule-based system (P <.001), but not for the consult system. CONCLUSION: Rule-based decision support can be combined with consult-based peer discussion to determine whether care is appropriate when guidelines are ambiguous. Poorly justified orders are often supportable after gathering information on the patient's presentation.
Authors: Ralph G Brindis; Pamela S Douglas; Robert C Hendel; Eric D Peterson; Michael J Wolk; Joseph M Allen; Manesh R Patel; Ira E Raskin; Robert C Hendel; Timothy M Bateman; Manuel D Cerqueira; Raymond J Gibbons; Linda D Gillam; John A Gillespie; Robert C Hendel; Ami E Iskandrian; Scott D Jerome; Harlan M Krumholz; Joseph V Messer; John A Spertus; Stephen A Stowers Journal: J Am Coll Cardiol Date: 2005-10-18 Impact factor: 24.094
Authors: Pamela Douglas; Ami E Iskandrian; Harlan M Krumholz; Linda Gillam; Robert Hendel; James Jollis; Eric Peterson; Jersey Chen; Frederick Masoudi; Emile Mohler; Robert L McNamara; Manesh R Patel; John Spertus Journal: J Am Coll Cardiol Date: 2006-11-01 Impact factor: 24.094
Authors: Pamela S Douglas; Bijoy Khandheria; Raymond F Stainback; Neil J Weissman; Ralph G Brindis; Manesh R Patel; Bijoy Khandheria; Joseph S Alpert; David Fitzgerald; Paul Heidenreich; Edward T Martin; Joseph V Messer; Alan B Miller; Michael H Picard; Paolo Raggi; Kim D Reed; John S Rumsfeld; Anthony E Steimle; Russ Tonkovic; Krishnaswami Vijayaraghavan; Neil J Weissman; Susan Bok Yeon; Ralph G Brindis; Pamela S Douglas; Robert C Hendel; Manesh R Patel; Eric Peterson; Michael J Wolk; Joseph M Allen Journal: J Am Coll Cardiol Date: 2007-07-10 Impact factor: 24.094
Authors: Robert C Hendel; Daniel S Berman; Marcelo F Di Carli; Paul A Heidenreich; Robert E Henkin; Patricia A Pellikka; Gerald M Pohost; Kim A Williams Journal: J Am Coll Cardiol Date: 2009-06-09 Impact factor: 24.094
Authors: Fay Y Lin; Allison M Dunning; Jagat Narula; Leslee J Shaw; Heidi Gransar; Daniel S Berman; James K Min Journal: J Am Coll Cardiol Date: 2013-05-22 Impact factor: 24.094
Authors: Gregory J Dehmer; Douglas Weaver; Matthew T Roe; Sarah Milford-Beland; Susan Fitzgerald; Anthony Hermann; John Messenger; Issam Moussa; Kirk Garratt; John Rumsfeld; Ralph G Brindis Journal: J Am Coll Cardiol Date: 2012-10-17 Impact factor: 24.094
Authors: Daniel I Rosenthal; Jeffrey B Weilburg; Thomas Schultz; Janet C Miller; Victoria Nixon; Keith J Dreyer; James H Thrall Journal: J Am Coll Radiol Date: 2006-10 Impact factor: 5.532